Mereo BioPharma (AgeTech UK) Biomed
Kinase inhibitors and other in pipeline for various, inclusing COPD. Mission is to provide new therapies to patients with chronically debilitating and life limiting rare diseases that have few, if any, other treatment options.
Investor Type:
N/A
Technology:
AgeTech Companies
Investment Stage:
N/A
Founded Date:
N/A
Industry:
UK AgeTech 2020
Employee Number:
N/A
Funding Status:
N/A
Number Of Exists:
N/A
Headquarters:
United Kingdom